Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease

Abstract

Despite the short follow-up period, our operationalization of the new preclinical AD recommendations confirmed that advancing preclinical stage led to higher proportions of subjects who progressed to MCI or dementia.